Back
Ticker avatar

Inhibikase Therapeutics, Inc. IKT · Insights

Inhibikase Therapeutics, Inc. operates as a clinical-stage pharmaceutical company that develops ther...
Price1.68
Market Cap234.42 M
Float111.9 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
OverviewFilingsInsightsDilutionNewsTranscripts
Search in Documents